Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07417930 · ClinicalTrials.gov registry record · NA
Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation
A NA study, sponsored by Klein Buendel.
- Not yet
- Registry status
- NA
- Development phase
- 516
- Enrollment target
NCT07417930: Clinical Trial NA study, sponsored by Klein Buendel.
NCT07417930 is a NA study that has not yet begun recruiting, run by Klein Buendel. The registered enrollment target is 516 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07417930, a NA study, has not yet begun recruiting, sponsored by Klein Buendel.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 516 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the effects of the hybrid ezParent program (e.g., web-based training program plus synchronous group sessions) on parent and child outcomes in a community setting serving parents of children 2-5 years old. Parent participants will complete surveys at baseline, and 10 and 24-weeks post baseline.
Primary Outcome
A 35-item scale measures parenting practices constituting both positive and negative dimensions of warmth/hostility and behavioral control appropriate for parents of children across the developmental span from young childhood through adolescence. Parents respond to each item on a 5-point scale from "Never" to "Always". Possible range= 0-175
Interventions
- BEHAVIORAL ezParent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
What is known before NCT07417930 opens enrollment
NCT07417930 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 1 intervention - of which ezParent is the first listed.
NCT07417930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07417930 about?
NCT07417930 is a clinical study titled "Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation". The goal of this study is to evaluate the effects of the hybrid ezParent program (e.g., web-based training program plus synchronous group sessions) on parent and child outcomes in a community setting serving parents of children 2-5 years old. Parent participants will complete surveys at baseline, an...
What is the current status of trial NCT07417930?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 516 participants. The study started on 2026-08-01. Estimated completion is 2028-09-30.
What interventions are being tested in trial NCT07417930?
The interventions under investigation include: ezParent (BEHAVIORAL).
Who is sponsoring clinical trial NCT07417930?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07417930's enrollment target sits among peer trials
516 191st of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI